HeraMED Limited (HMD.AX)
AUD 0.02
(0.0%)
AUD 0.02
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -6.78 Million AUD | 3.65% |
| 2022 | -7.04 Million USD | 7.44% |
| 2021 | -7.6 Million AUD | -55.89% |
| 2020 | -4.87 Million AUD | -8.37% |
| 2019 | -4.5 Million AUD | -19.54% |
| 2018 | -3.76 Million AUD | -266.38% |
| 2017 | -1.02 Million AUD | 63.97% |
| 2016 | -2.85 Million AUD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -3.21 Million AUD | 0.0% |
| 2023 Q2 | -3.23 Million AUD | 0.0% |
| 2023 FY | -6.78 Million AUD | 3.65% |
| 2023 Q4 | -3.54 Million AUD | 0.0% |
| 2022 Q2 | -4.39 Million AUD | 0.0% |
| 2022 Q4 | -2.57 Million AUD | 0.0% |
| 2022 FY | -7.04 Million USD | 7.44% |
| 2021 FY | -7.6 Million AUD | -55.89% |
| 2021 Q4 | -5.42 Million AUD | 0.0% |
| 2021 Q2 | -2.25 Million AUD | 0.0% |
| 2020 Q4 | -2.78 Million AUD | 0.0% |
| 2020 FY | -4.87 Million AUD | -8.37% |
| 2020 Q2 | -2.04 Million AUD | 0.0% |
| 2019 FY | -4.5 Million AUD | -19.54% |
| 2019 Q4 | -2.58 Million AUD | 0.0% |
| 2019 Q2 | -1.92 Million AUD | 0.0% |
| 2018 Q4 | -1.11 Million AUD | 0.0% |
| 2018 FY | -3.76 Million AUD | -266.38% |
| 2018 Q2 | -1.64 Million AUD | 0.0% |
| 2018 Q1 | -1.64 Million AUD | 0.0% |
| 2017 FY | -1.02 Million AUD | 63.97% |
| 2017 Q4 | -1.64 Million AUD | 0.0% |
| 2016 FY | -2.85 Million AUD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| 4DMedical Limited | -35.97 Million AUD | 81.145% |
| Adherium Limited | -10.22 Million AUD | 33.651% |
| Aroa Biosurgery Limited | -9.74 Million AUD | 30.412% |
| Atomo Diagnostics Limited | -6.84 Million AUD | 0.937% |
| Anteris Technologies Ltd | -67.33 Million AUD | 89.925% |
| Control Bionics Limited | -5.91 Million AUD | -14.71% |
| CardieX Limited | -6.76 Million AUD | -0.271% |
| Compumedics Limited | -338 Thousand AUD | -1907.002% |
| Cochlear Limited | 356.8 Million AUD | 101.901% |
| CleanSpace Holdings Limited | -3.12 Million AUD | -116.929% |
| Cyclopharm Limited | -4.7 Million AUD | -44.309% |
| EMVision Medical Devices Ltd | -2.72 Million AUD | -148.522% |
| Nova Eye Medical Limited | -8.79 Million AUD | 22.825% |
| Imricor Medical Systems, Inc. | -22.62 Million AUD | 70.018% |
| ImpediMed Limited | -19.79 Million AUD | 65.722% |
| InhaleRx Limited | -1.44 Million AUD | -370.02% |
| LBT Innovations Limited | -3.74 Million AUD | -81.381% |
| Micro-X Limited | -9.76 Million AUD | 30.531% |
| Neurotech International Limited | -5.06 Million AUD | -33.82% |
| OncoSil Medical Limited | -11.91 Million AUD | 43.06% |
| PolyNovo Limited | 5.26 Million AUD | 228.943% |
| Respiri Limited | -7.12 Million AUD | 4.847% |
| SomnoMed Limited | -12.24 Million AUD | 44.586% |
| Universal Biosensors, Inc. | -6.74 Million AUD | -0.625% |
| Uscom Limited | -2.07 Million AUD | -226.963% |
| Visioneering Technologies, Inc. | -5.06 Million AUD | -33.977% |